BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 37239269)

  • 1. Melatonin as a Chronobiotic/Cytoprotective Agent in REM Sleep Behavior Disorder.
    Cardinali DP; Garay A
    Brain Sci; 2023 May; 13(5):. PubMed ID: 37239269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. REM sleep behaviour disorder.
    Dauvilliers Y; Schenck CH; Postuma RB; Iranzo A; Luppi PH; Plazzi G; Montplaisir J; Boeve B
    Nat Rev Dis Primers; 2018 Aug; 4(1):19. PubMed ID: 30166532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid Eye Movement Sleep Behavior Disorder and Other Rapid Eye Movement Parasomnias.
    Howell MJ
    Continuum (Minneap Minn); 2020 Aug; 26(4):929-945. PubMed ID: 32756229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid Eye Movement Sleep Behavior Disorder and Neurodegenerative Disease.
    Howell MJ; Schenck CH
    JAMA Neurol; 2015 Jun; 72(6):707-12. PubMed ID: 25867792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. REM Sleep Behavior Disorder in Parkinson's Disease and Other Synucleinopathies.
    St Louis EK; Boeve AR; Boeve BF
    Mov Disord; 2017 May; 32(5):645-658. PubMed ID: 28513079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group.
    Schenck CH; Montplaisir JY; Frauscher B; Hogl B; Gagnon JF; Postuma R; Sonka K; Jennum P; Partinen M; Arnulf I; Cochen de Cock V; Dauvilliers Y; Luppi PH; Heidbreder A; Mayer G; Sixel-Döring F; Trenkwalder C; Unger M; Young P; Wing YK; Ferini-Strambi L; Ferri R; Plazzi G; Zucconi M; Inoue Y; Iranzo A; Santamaria J; Bassetti C; Möller JC; Boeve BF; Lai YY; Pavlova M; Saper C; Schmidt P; Siegel JM; Singer C; St Louis E; Videnovic A; Oertel W
    Sleep Med; 2013 Aug; 14(8):795-806. PubMed ID: 23886593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. REM Behavior Disorder: Implications for PD Therapeutics.
    Feuerstein JS; Amara A
    Curr Neurol Neurosci Rep; 2023 Nov; 23(11):727-734. PubMed ID: 37831394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. REM behavior disorder: When Parkinson's disease meets Morpheus.
    Dodet P
    Rev Neurol (Paris); 2023 Oct; 179(7):667-674. PubMed ID: 37598085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of REM Sleep Behavior Disorder.
    Jung Y; St Louis EK
    Curr Treat Options Neurol; 2016 Nov; 18(11):50. PubMed ID: 27752878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Concepts and Controversies in the Management of REM Sleep Behavior Disorder.
    Matar E; McCarter SJ; St Louis EK; Lewis SJG
    Neurotherapeutics; 2021 Jan; 18(1):107-123. PubMed ID: 33410105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [REM sleep behavior disorder as a prodromal stage of α-synucleinopathies: symptoms, epidemiology, pathophysiology, diagnosis and therapy].
    Oertel WH; Depboylu C; Krenzer M; Vadasz D; Ries V; Sixel-Döring F; Mayer G
    Nervenarzt; 2014 Jan; 85(1):19-25. PubMed ID: 24399499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. REM sleep behavior disorder as a complex condition with heterogeneous underlying disorders: clinical management and prognostic implications [Commentary].
    Schenck CH
    Sleep Breath; 2022 Sep; 26(3):1289-1298. PubMed ID: 35239134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timeline of Rapid Eye Movement Sleep Behavior Disorder in Overt Alpha-Synucleinopathies.
    Stang CD; Mullan AF; Hajeb M; Camerucci E; Turcano P; Martin P; Mielke MM; Josephs KA; Bower JH; St Louis EK; Boeve BF; Savica R
    Ann Neurol; 2021 Feb; 89(2):293-303. PubMed ID: 33155696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson's Disease.
    Pérez-Lloret S; Cardinali DP
    Front Pharmacol; 2021; 12():650597. PubMed ID: 33935759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic REM sleep behaviour disorder and neurodegeneration - an update.
    Högl B; Stefani A; Videnovic A
    Nat Rev Neurol; 2018 Jan; 14(1):40-55. PubMed ID: 29170501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. REM sleep behaviour disorder: not just a bad dream.
    Matar E; Lewis SJ
    Med J Aust; 2017 Sep; 207(6):262-268. PubMed ID: 28899330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin therapy for REM sleep behavior disorder: a critical review of evidence.
    McGrane IR; Leung JG; St Louis EK; Boeve BF
    Sleep Med; 2015 Jan; 16(1):19-26. PubMed ID: 25454845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid eye movement sleep behavior disorder and the link to alpha-synucleinopathies.
    Barone DA; Henchcliffe C
    Clin Neurophysiol; 2018 Aug; 129(8):1551-1564. PubMed ID: 29883833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder.
    Boeve BF; Silber MH; Ferman TJ; Lin SC; Benarroch EE; Schmeichel AM; Ahlskog JE; Caselli RJ; Jacobson S; Sabbagh M; Adler C; Woodruff B; Beach TG; Iranzo A; Gelpi E; Santamaria J; Tolosa E; Singer C; Mash DC; Luca C; Arnulf I; Duyckaerts C; Schenck CH; Mahowald MW; Dauvilliers Y; Graff-Radford NR; Wszolek ZK; Parisi JE; Dugger B; Murray ME; Dickson DW
    Sleep Med; 2013 Aug; 14(8):754-62. PubMed ID: 23474058
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.